Curaleaf Holdings, Inc. filed a current report on November 10, 2026, disclosing that the company has received all required competition law clearances for its proposed acquisition of Aurora Cannabis.

Key Highlights

  • All clearances obtained: Curaleaf confirmed it has received all required competition law clearances for the proposed Aurora Cannabis acquisition, according to the filing.
  • Statement date: The confirmation was issued by Curaleaf on November 10, 2026.
  • Filing type: The current report was filed as a written communication pursuant to Rule 425 under the Securities Act.
  • No securities registered: The filing states that no securities are registered pursuant to Section 12(b) of the Act.
  • Signed by: The report was signed by Peter Clateman, Chief Legal Officer of Curaleaf Holdings, Inc.

Curaleaf Clears Regulatory Hurdle in Aurora Cannabis Acquisition

Curaleaf Holdings, Inc. disclosed on November 10, 2026, that it has received all required competition law clearances in connection with its proposed acquisition of Aurora Cannabis. The company issued a statement to that effect on the same date, according to the filing. The report was submitted as a written communication under Rule 425 of the Securities Act of 1933, as indicated by the checked box on the cover page of the Form 8-K.

The filing was made under Item 8.01 (Other Events) and includes a press release dated November 10, 2026, as Exhibit 99.1. Curaleaf is incorporated in British Columbia, Canada, and maintains its principal executive offices at 250 Harbor Drive, Third Floor, Stamford, Connecticut 06902. The filing notes that the information contained in the current report, including Exhibit 99.1, "shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934." The report was signed by Peter Clateman, Chief Legal Officer, on behalf of Curaleaf Holdings, Inc.

The filing indicates that no securities of the registrant are registered pursuant to Section 12(b) of the Act, and the company is not identified as an emerging growth company in this filing.

What Was Disclosed

Curaleaf Holdings, Inc. reported via a Rule 425 current report that it has received all required competition law clearances for its proposed acquisition of Aurora Cannabis, with the statement issued and filed on November 10, 2026.